What is eAG? Estimated Average Glucose

Executive Summary

eAG, which stands for Estimated Average Glucose, is a highly standardized clinical translation metric in diabetes management. It converts your laboratory A1C percentage—which is reported as a fraction of sugar-coated hemoglobin—into the familiar units of measurement (mg/dL or mmol/L) used on home blood glucose meters and continuous monitors. Established by the landmark global ADAG study, eAG bridges the educational gap for patients, allowing them to easily compare their quarterly diagnostic lab results with their daily, real-time blood sugar snapshots.

The Rationale for eAG: Bridging the Educational Gap

For decades, patients managing diabetes faced a significant psychological and educational barrier when receiving their laboratory results. A physician would review their quarterly blood work and explain, "Your A1C has risen to 8.2%." However, when the patient returned home and pricked their finger, their blood glucose meter would display a completely different set of numbers, such as "189 mg/dL."

This mismatch occurred because:

Daily Meters: Measure the concentration of free glucose molecules floating in blood plasma at one exact millisecond.
The A1C Test: Measures the percentage of hemoglobin molecules that have chemically bonded with glucose over a 3-month period.

To resolve this confusion and help patients understand their long-term average in the context of their daily targets, the American Diabetes Association (ADA), the European Association for the Study of Diabetes (EASD), and the International Diabetes Federation (IDF) launched an international task force in the mid-2000s. Their goal was to create a scientifically validated formula that could translate the A1C percentage into a daily blood sugar average. This calculated value was designated as eAG (Estimated Average Glucose).

The ADAG Study: The Scientific Foundation

The mathematical relationship used to calculate eAG was established by the ADAG (A1C-Derived Average Glucose) study, published in the clinical journal Diabetes Care in 2008.

Prior to this study, older mathematical models were based on limited patient groups and less precise monitoring technology. The ADAG study was designed to be the most rigorous, comprehensive evaluation of glucose translation ever performed.

[507 Diverse Subjects] --> [12 Weeks of 48-Hour CGM (4x) + Daily SMBG (7x/day)] --> [2,700+ Data Points per Subject] --> [Linear Regression Analysis]

Diverse Study Population: The trial recruited 507 subjects across 10 medical centers worldwide. The cohort included 268 patients with Type 1 diabetes, 159 patients with Type 2 diabetes, and 80 healthy individuals without diabetes, spanning diverse ethnic groups to ensure global clinical validity.
Intense Monitoring Protocol: Over a 12-week period, researchers collected thousands of glucose readings from each participant. This was achieved by performing 48-hour continuous glucose monitoring (CGM) four times during the study, combined with seven-day-a-week self-monitoring of blood glucose (SMBG) finger-pricks (taken seven times daily).
Data Integration: By combining these real-time, continuous glucose logs with the subjects' baseline and 12-week laboratory A1C draws, researchers had access to over 2,700 data points per subject.
Regression Analysis: Statisticians used linear regression analysis to plot A1C against average glucose, revealing a highly stable, linear mathematical correlation.

The Mathematical Formulas

The linear regression analysis from the ADAG study produced a highly stable equation. For every 1.0% change in A1C, the estimated average glucose changes by approximately 29 mg/dL (or 1.6 mmol/L).

The US Formula (mg/dL)

To convert an A1C percentage into estimated average glucose in milligrams per deciliter (mg/dL), clinical instruments use the following linear equation:

eAG (mg/dL) = (28.7 * A1C) - 46.7

Example Calculation: If a patient's laboratory A1C is 7.0%:

eAG = (28.7 * 7.0) - 46.7 = 154.2 mg/dL

Therefore, an A1C of 7.0% represents an estimated average blood sugar of 154 mg/dL over the past 90 days.

The International Formula (mmol/L)

For regions using the international SI units of millimoles per liter (mmol/L), the formula is:

eAG (mmol/L) = (1.59 * A1C) - 2.59

Example Calculation: For an A1C of 7.0%:

eAG = (1.59 * 7.0) - 2.59 = 8.54 mmol/L

A1C (%)	eAG (mg/dL)	eAG (mmol/L)	Clinical Classification
5.0%	97 mg/dL	5.4 mmol/L	Optimal Metabolic Health
5.5%	111 mg/dL	6.2 mmol/L	Normal Adult Baseline
5.7%	117 mg/dL	6.5 mmol/L	Prediabetes Threshold
6.0%	126 mg/dL	7.0 mmol/L	High-Risk Prediabetes
6.5%	140 mg/dL	7.8 mmol/L	Diabetes Diagnostic Threshold
7.0%	154 mg/dL	8.6 mmol/L	Standard Treatment Target
7.5%	169 mg/dL	9.4 mmol/L	Sub-optimal Glycemic Control
8.0%	183 mg/dL	10.2 mmol/L	High Risk of Vascular Damage
9.0%	212 mg/dL	11.8 mmol/L	Severe Hyperglycemia
10.0%	240 mg/dL	13.4 mmol/L	Urgent Clinical Intervention Required

Why eAG and Home Meter Averages Mismatch

A frequent source of frustration for patients is discovering that their home blood glucose meter's "30-day average" or "90-day average" printed on the screen does not match the eAG calculated on their laboratory report. This mismatch occurs due to three primary factors:

1. Sampling Bias

Your home meter only knows your blood sugar when you physically prick your finger and test. Most patients test in the morning (fasting) or before meals. This means they are completely missing their post-meal spikes and the hours spent asleep.

If you only test when your sugar is at its lowest (fasting) or when you suspect you are low, your home meter's calculated average will be significantly lower than your true eAG, which captures every single second of the past 90 days.

2. Variation in Glycation Speed (Inter-Individual Variability)

Human bodies are not identical machines. The speed at which glucose bonds to hemoglobin varies between individuals based on their biology, a concept known as glycation kinetics.

Fast Glycators: Some individuals have red blood cell membranes that are highly permeable to glucose, or their hemoglobin has a higher affinity for bonding. These individuals will have a falsely high A1C and eAG compared to their actual average blood sugar.
Slow Glycators: Others have a naturally slower rate of glycation, resulting in a falsely low A1C and eAG compared to their true average daily glucose.

3. Red Blood Cell Lifespan Differences

Because the eAG calculation assumes your red blood cells live for exactly 120 days, any condition that alters red blood cell lifespan will skew the calculation. For example, in iron deficiency anemia, red blood cells survive longer in circulation, allowing them to accumulate more glucose. This leads to a falsely high eAG that does not reflect your actual daily average blood sugar.

GMI vs. eAG: What is the Difference?

With the rise of Continuous Glucose Monitors (CGMs), a new metric has emerged called GMI (Glucose Management Indicator). While both eAG and GMI estimate your long-term glucose control, they are derived from different sources:

eAG: Is derived strictly from a laboratory A1C blood test. It uses the chemistry of glycated hemoglobin to estimate what your daily glucose average was.
GMI: Is derived strictly from a CGM sensor's glucose logs over a 12 to 14-day period. It uses a formula to estimate what your lab A1C is likely to be on your next draw.

Because GMI is based on direct glucose measurements rather than the chemical bonding of proteins, it is immune to errors caused by anemia, hemoglobin variants, or individual glycation speeds.

Clinical Guidance

If you use a CGM, expect your GMI and your lab eAG to differ by up to 0.5% or 15 mg/dL. This is a normal reflection of the biological differences between tracking glucose in tissue fluid (CGM) versus measuring glycated proteins (Lab).

Convert Your Lab A1C to Estimated Average Glucose (eAG) Now →

Frequently Asked Questions

1. What is the difference between eAG and GMI?

eAG (Estimated Average Glucose) is a calculated value derived strictly from a laboratory A1C blood draw, converting your HbA1c percentage into mg/dL or mmol/L. GMI (Glucose Management Indicator) is a value calculated by your Continuous Glucose Monitor (CGM) software based on your average sensor glucose readings over 12–14 days, predicting what your lab A1C is likely to be.

2. Why is the ADAG equation considered valid across diverse ethnic populations?

The ADAG study was specifically designed to ensure global clinical validity. Researchers recruited over 500 participants across 10 centers worldwide, ensuring a highly diverse cohort of Caucasian, African American, Hispanic, Asian, and multi-ethnic individuals. The regression analysis proved that the linear correlation between A1C and average glucose remained highly stable across all ethnic groups.

3. Why does my 90-day home meter average not match my lab's eAG?

This is primarily caused by sampling bias. Your home glucose meter only calculates the average of the specific times you chose to prick your finger (usually when fasting or before meals). It misses post-meal spikes, exercise drops, and the hours you spent asleep. Your lab's eAG is derived from your A1C, which records every single second of sugar exposure over the past 90 days.

4. What happens to eAG if I have a condition like sickle cell trait?

If you have a hemoglobin variant like Sickle Cell Trait (Hemoglobin S) or Hemoglobin C, the chemical structure of your beta globin chains is altered. This can prevent standard laboratory assays from measuring your glycated hemoglobin accurately, resulting in a highly inaccurate, falsely elevated or lowered A1C and eAG. If you have a variant, your doctor should order a fructosamine test instead.

5. Can taking large amounts of Vitamin C or E alter my calculated eAG?

Yes. Taking very high doses of antioxidants like Vitamin C (1,000 mg or more daily) can chemically interfere with the oxidation reactions used in some laboratory assays to measure A1C. This interference can cause the lab to report a falsely low A1C, which will translate into an inaccurate, falsely low calculated eAG.

6. Is there an easy mental shortcut to estimate my eAG from my A1C without a calculator?

Yes. A highly effective mental shortcut is to remember that an A1C of 6.0% equals an eAG of 126 mg/dL (the threshold for diabetes). For every 1.0% change in A1C above or below this baseline, simply add or subtract 29 mg/dL (or roughly 30 mg/dL for quick math).

Example: For an A1C of 7.0%, add 29 to 126, which yields 155 mg/dL (very close to the official 154 mg/dL).

7. Why is eAG reported in both mg/dL and mmol/L internationally?

Endocrinology uses two primary units of concentration. The United States, Japan, and parts of Europe report blood sugar in milligrams per deciliter (mg/dL). The United Kingdom, Canada, and Australia use the international SI standard of millimoles per liter (mmol/L). Reporting eAG in both units ensures that patients and clinicians worldwide can interpret results using their familiar metrics.

8. Does eAG stand for "estimated average glucose" or "estimated A1c glucose"?

eAG stands officially for Estimated Average Glucose. It was designated by the ADA, EASD, and IDF as the standard clinical term to represent the 90-day average blood sugar value calculated from a laboratory A1C test.

9. Can a sudden change in lifestyle lower my eAG faster than my A1C?

No. Because eAG is mathematically derived directly from your A1C percentage using the formula eAG = (28.7 * A1C) - 46.7, it is impossible for your eAG to change independently of your A1C. Both values represent the exact same 90-day biological rolling average; when your A1C drops, your eAG will drop in perfect lockstep.

10. How does pregnancy alter the accuracy of the eAG calculation?

During pregnancy, maternal red blood cell turnover accelerates and blood volume expands (hemodilution). This naturally lowers your A1C reading even if your actual average glucose has not changed. Using the standard ADAG formula during pregnancy will yield a falsely low eAG that can dangerously hide gestational diabetes.

11. What is the scientific definition of "glycation index" and how does it explain eAG mismatches?

The Hemoglobin Glycation Index (HGI) measures the difference between a patient's observed laboratory A1C and their predicted A1C based on direct glucose measurements. A high HGI indicates that a patient is a "fast glycator," naturally binding glucose to their hemoglobin faster than average. A low HGI indicates a "slow glycator." This biological variability explains why two patients with the exact same daily average blood sugar can have different eAG values on their lab reports.

What is eAG? Estimated Average Glucose